Byam Rebecca bought HCWB
May 22, 2026 · Form 4 insider transaction
Byam Rebecca bought 14,235 shares of HCW Biologics Inc. at $1.41 per share, a transaction worth $20.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
14,235
Price
$1.41
Total value
$20.0K
InsiderByam Rebecca
Role—
CompanyHCW Biologics Inc. (HCWB)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 22, 2026
Filing dateMay 27, 2026
Shares owned after57,245
OwnershipDirect
10b5-1 planNo
AmendedNo